In this study, there was no opportunity to determine whether the increased leptin levels observed in climacteric women may be predictive of certain outcomes (i.e., do climacteric women with higher leptin levels tend to develop obesity, or metabolic syndrome, or cardiovascular diseases or certain types of cancer). The gene discussed is LEP; the disease is obesity disorder.